Invitrogen™ Human DELE Synthetic Peptide

Ref.: BL-RE-175462Manufacturer ref.: PEP-1445 50 μg
€149.00 excl. VAT

DELE Synthetic Peptide, PEP-1445, from Invitrogen.

Gene ID (Enter)
9812
Species
Human
Purification method
Purified
Accession number
Q14154
Common name
Human DELE
Brand
Invitrogen

DELE Synthetic Peptide, PEP-1445, from Invitrogen.

DELE Synthetic Peptide, PEP-1445, from Invitrogen.

DELE is a recently identified DAP3-binding protein that is thought to be important in the induction of death receptor-mediated apoptosis. Transfected cells that stably express DELE were found to be susceptible to apoptosis induction by TNF-Alpha and TRAIL, whereas reducing DELE expression by siRNA rescued these cells from apoptosis induction. Furthermore, the reduction of DELE expression also inhibited the activation of caspase-3, caspase-8 and caspase-9 following stimulation by TNF-Alpha, anti-Fas, or TRAIL, indicating the importance of DELE in apoptosis mediated by death receptors.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15205359
Specifications
Gene ID (Enter)9812
SpeciesHuman
Purification methodPurified
Accession numberQ14154
Common nameHuman DELE
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)KIAA0141
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-1445
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.